Financial & competing interests disclosure
The author is an inventor on a patent application wherein the use of the IFN gene activity to predict the response outcome to IFN-b is described and owns equity in Preselect Diagnostics BV. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript
Financial & competing interests disclosure
The author is an inventor on a patent application wherein the use of the IFN gene activity to predict the response outcome to IFN-β is described and owns equity in Preselect Diagnostics BV. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.